Delivery Order SPE2DB22D6029-SPE2DB24FU1BD

Award Date 5/28/24
Potential Completion Date 5/29/24
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order with a Firm Fixed Price of $13,682.37 and has an Ultimate Completion Date of May 16, 2024. Amerisourcebergen holds a...
This federal contract award is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, and does not have a set-aside designation. The contract is a Delivery Order with a Firm Fixed Price pricing type, a ceiling value of $8,873.39, and a period of performance through August 21,...
This federal contract award is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) by the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The firm-fixed-price delivery order has a ceiling value of $2,915.60 and a completion date of September 6, 2024. This award is not a set-aside contract. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $7,789.34, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of November 25, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $4,472.64 to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen provides a comprehensive range of...
This federal contract award is for the delivery of Humulin R 500 Unit/mL Kwikpens (3mL) to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, on a firm-fixed-price basis with a total ceiling value of $2,744.76. The contract has a completion date of July 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up...
This federal contract award is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML pharmaceutical products to the Defense Logistics Agency (DLA). The $12,910.53 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 30, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This federal contract award is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a prescription medication, to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on a Firm Fixed Price basis for a ceiling value of $12,770.18. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,298.58, is a delivery order for the supply of "HUMULIN R 500 UNIT/ML KWIKPEN 3ML", a pharmaceutical product. The contract has an ultimate completion date of December 30, 2024 and is a firm fixed price agreement. This award is part of a larger Indefinite Delivery Contract (IDC) valued...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML pharmaceutical products to the Defense Logistics Agency (DLA). The $1,863.60 firm fixed price delivery order has a completion date of June 17, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
  • SPE2DB22D6029
    Indefinite Delivery Contract
  • SPE2DB22D6029-SPE2DB24FU1BD
    Delivery Order

This federal contract award is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $4,472.64, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 8/27/24, 9:07 AM